A recent meta-analysis reported that carriers of the TM6SF2 E167K gene variant have a 2.1-fold higher risk of NAFLD than non-carriers [93]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.